联合检测阿黑皮素原与α-促黑素细胞激素对重症患者进展为持续性炎症-免疫抑制-分解代谢综合征的预测价值
该回顾性队列研究纳入2020年3月至2021年7月南京鼓楼医院ICU收治的63例重症患者,记录入ICU首日SOFA、APACHEⅡ评分及血清POMC、α-MSH水平,观察ICU期间PIICS发生率。47例(75%)进展为PIICS,16例(25%)未进展。PIICS组入ICU首日POMC水平显著高于非PIICS组,α-MSH水平则相反;POMC与SOFA评分及PIICS发生正相关,α-MSH与APACHEⅡ评分、SOFA评分及PIICS发生负相关。ROC曲线显示两者联合检测预测PIICS的AUC为0.743,敏感度87.2%、特异度50.0%。
要点
- 63例重症患者中47例(75%)在ICU期间进展为PIICS,16例(25%)未进展。
- PIICS组入ICU首日POMC为2149.02(1939.54,2761.06)ng/L,高于非PIICS组的1884.73(1651.83,2234.99)ng/L,P<0.05。
- PIICS组入ICU首日α-MSH为1526.95(982.84,2092.94)ng/L,低于非PIICS组的2182.76(1500.57,3401.51)ng/L,P<0.05。
- 入ICU首日POMC与SOFA评分及PIICS发生正相关(r分别为0.275、0.279,均P<0.05);α-MSH与APACHEⅡ评分、SOFA评分及PIICS发生负相关(r分别为-0.291、-0.339、-0.287,均P<0.05)。
- POMC与α-MSH联合检测预测PIICS的AUC为0.743,敏感度87.2%、特异度50.0%。
适用人群与场景
- 2020年3月至2021年7月南京鼓楼医院ICU收治的重症患者,共63例。
研究设计与关键结果
- 回顾性队列研究,纳入63例重症患者,47例(75%)进展为PIICS、16例(25%)未进展。
- PIICS组APACHEⅡ评分和SOFA评分显著高于非PIICS组,其他基线特征无统计学差异。
- 入ICU首日POMC在PIICS组为2149.02(1939.54,2761.06)ng/L,高于非PIICS组的1884.73(1651.83,2234.99)ng/L;α-MSH在PIICS组为1526.95(982.84,2092.94)ng/L,低于非PIICS组的2182.76(1500.57,3401.51)ng/L,均P<0.05。
- 入ICU首日POMC与SOFA评分及PIICS发生正相关(r分别为0.275、0.279,均P<0.05);α-MSH与APACHEⅡ评分、SOFA评分及PIICS发生负相关(r分别为-0.291、-0.339、-0.287,均P<0.05)。
- POMC与α-MSH联合检测预测PIICS的AUC为0.743,敏感度87.2%、特异度50.0%。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为入ICU首日联合检测POMC与α-MSH对重症患者进展为PIICS有一定预测价值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the predictive value of combined detection of pro-opiomelanocortin (POMC) and α-melanocyte stimulating hormone (α-MSH) for progression to persistent inflammation, immunosuppression, and catabolism syndrome (PIICS) in critical patients.
METHODS: A retrospective cohort study was conducted, including critical patients admitted to the intensive care unit (ICU) of Nanjing Drum Tower Hospital between March 2020 and July 2021. Baseline data were collected, encompassing gender, age, infection source, smoking history, alcohol consumption history, and underlying diseases. On the first day of ICU admission, sequential organ failure assessment (SOFA), acute physiology and chronic health evaluation II(APACHE II), serum POMC and α-MSH levels were recorded, along with the incidence of PIICS during ICU stay. Spearman correlation analysis was used to evaluate the correlation between POMC and α-MSH levels and disease severity. Receiver operator characteristic curve (ROC curve) was constructed to evaluate the predictive accuracy of POMC and α-MSH for PIICS progression.
RESULTS: A total of 63 critical patients were included, among whom 47 (75%) developed PIICS and 16 (25%) did not. Compared with the non-PIICS group, the PIICS group showed significantly higher APACHE II and SOFA scores, while no statistical differences were observed in other baseline characteristics. The POMC level on the first day of ICU admission was significantly higher in the PIICS group than in the non-PIICS group, while the α-MSH level showed the opposite trend [POMC (ng/L): 2 149.02 (1 939.54, 2 761.06) vs. 1 884.73 (1 651.83, 2 234.99), α-MSH (ng/L): 1 526.95 (982.84, 2 092.94) vs. 2 182.76 (1 500.57, 3 401.51), both P < 0.05]. Spearman correlation analysis demonstrated that the serum POMC level at admission to the ICU was positively correlated with the SOFA score and the occurrence of PIICS (with r values of 0.275 and 0.279, respectively, both P < 0.05). In contrast, the α-MSH level was negatively correlated with the APACHE II score, SOFA score, and the occurrence of PIICS (with r values of -0.291, -0.339, and -0.287, respectively, all P < 0.05). ROC curve analysis demonstrated that both POMC and α-MSH had certain predictive value for the progression of critical patients to PIICS. The predictive value was the greatest when POMC and α-MSH were detected in combination, area under the curve (AUC) was 0.743, with the sensitivity and specificity for predicting PIICS being 87.2% and 50.0%, respectively.
CONCLUSIONS: The combined detection of POMC and α-MSH on the first day of ICU admission showed certain predictive value for the progression of critical patients to PIICS.
参考来源
- Chen J, Chen X, Li H, et al. [Predictive value of combined detection of pro-opiomelanocortin and α-melanocyte stimulating hormone for progression to persistent inflammation, immunosuppression, and catabolism syndrome in critical patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41500693. doi:10.3760/cma.j.cn121430-20240911-00446
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。